tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IMRX Stock Latest News

Positive Buy Rating for Immuneering Driven by Promising Clinical Data and Competitive Positioning
RatingsPositive Buy Rating for Immuneering Driven by Promising Clinical Data and Competitive Positioning
8d ago
IMRX
Immuneering price target lowered to $21 from $25 at Oppenheimer
PremiumThe Fly
Immuneering price target lowered to $21 from $25 at Oppenheimer
1M ago
IMRX
Positive Outlook for Immuneering: Buy Rating Backed by Strategic Developments and Promising Clinical Data
PremiumRatings
Positive Outlook for Immuneering: Buy Rating Backed by Strategic Developments and Promising Clinical Data
1M ago
IMRX
Immuneering Corp. Reports Promising Q1 2025 Results
PremiumCompany Announcements
Immuneering Corp. Reports Promising Q1 2025 Results
1M ago
IMRX
Immuneering reports Q1 EPS (42c), consensus (58c)
PremiumThe Fly
Immuneering reports Q1 EPS (42c), consensus (58c)
1M ago
IMRX
Immuneering’s Promising Potential: Buy Rating Backed by Strategic Expansion and Data Generation
PremiumRatingsImmuneering’s Promising Potential: Buy Rating Backed by Strategic Expansion and Data Generation
2M ago
IMRX
Immuneering Corp. Reports Promising Cancer Trial Results
Premium
Company Announcements
Immuneering Corp. Reports Promising Cancer Trial Results
3M ago
IMRX
Immuneering management to meet with Oppenheimer
Premium
The Fly
Immuneering management to meet with Oppenheimer
3M ago
IMRX
Immuneering’s Strategic Advancements and Financial Strength Bolster Buy Rating
PremiumRatings
Immuneering’s Strategic Advancements and Financial Strength Bolster Buy Rating
3M ago
IMRX
Immuneering reports Q4 EPS (58c), consensus (44c)
PremiumThe Fly
Immuneering reports Q4 EPS (58c), consensus (44c)
3M ago
IMRX
Immuneering appoints Matushansky as Chief Medical Officer
PremiumThe Fly
Immuneering appoints Matushansky as Chief Medical Officer
3M ago
IMRX
Immuneering management to meet with Oppenheimer
PremiumThe Fly
Immuneering management to meet with Oppenheimer
3M ago
IMRX
Immuneering Corp. Class A (IMRX) Q4 Earnings Cheat Sheet
PremiumPre-EarningsImmuneering Corp. Class A (IMRX) Q4 Earnings Cheat Sheet
3M ago
IMRX
Immuneering announces clinical supply agreement with Regeneron
Premium
The Fly
Immuneering announces clinical supply agreement with Regeneron
4M ago
IMRX
REGN
Immuneering announces update from its Phase 2a arm studying IMM-1-104
Premium
The Fly
Immuneering announces update from its Phase 2a arm studying IMM-1-104
5M ago
IMRX
3 Penny Stocks to Watch Now, 1/9/25
PremiumMarket News
3 Penny Stocks to Watch Now, 1/9/25
5M ago
HOTH
IMRX
Immuneering announce data update from Phase 2a trial of IMM-1-104
PremiumThe Fly
Immuneering announce data update from Phase 2a trial of IMM-1-104
5M ago
IMRX
Immuneering launches Pancreatic Cancer Advisory Board
PremiumThe Fly
Immuneering launches Pancreatic Cancer Advisory Board
6M ago
IMRX
Immuneering to present data from Phase 2a trial of IMM-1-104 in early January
PremiumThe Fly
Immuneering to present data from Phase 2a trial of IMM-1-104 in early January
6M ago
IMRX
Immuneering downgraded to Underweight from Equal Weight at Morgan Stanley
PremiumThe FlyImmuneering downgraded to Underweight from Equal Weight at Morgan Stanley
6M ago
IMRX
Immuneering granted FDA Fast Track designation for IMM-1-104
Premium
The Fly
Immuneering granted FDA Fast Track designation for IMM-1-104
6M ago
IMRX
Immuneering Corp. Reports Q3 Loss, Highlights Progress
Premium
Company Announcements
Immuneering Corp. Reports Q3 Loss, Highlights Progress
7M ago
IMRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >